Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Antiplatelet Drugs Market Size

The global antiplatelet drugs market was valued at USD 4795.4 million in 2023, driven by the rising incidence of cardiovascular diseases along with the technological advancements in drug development across the globe. The market is expected to grow at a CAGR of 2.1% during the forecast period of 2024-2032, with the values likely to rise from USD 4863.9 million in 2024 to USD 5739.6 million by 2032.

Global Antiplatelet Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Antiplatelet Drugs Market Outlook

  • The market value is impacted by rising approvals for rising incidence of cardiovascular diseases in the geriatric population along with increasing approvals for generic drugs by the regulatory authorities such as FDA.
  • By region, North America is expected to lead the market share. The market value can be attributed to the presence of prominent healthcare companies and increasing research initiatives to develop effective alternatives for consumers.
  • Aspirin leads the market share by drugs. The rising application of the drug in managing multiple cardiovascular conditions, along with other factors such as easy accessibility and affordability contribute to its significant market share.

Global Antiplatelet Drugs Market Overview

Antiplatelet drug belongs to a class of pharmaceuticals that decrease platelet aggregation, thus, preventing the formation of thrombus. They help prevent platelets from clumping together to form a clot and decrease the formation of potentially harmful blood clots. They show high efficacy in the arterial circulation, where anticoagulants are less effective. The increased use of this medication in primary and secondary prevention of thrombotic cerebrovascular or cardiovascular disorders coupled with the growing emphasis on preventive healthcare measures is significantly contributing to the market growth.

Global Antiplatelet Drugs Market Growth Factors

Rising Incidence of Cardiovascular Diseases

Cardiovascular diseases, such as coronary artery disease, stroke, and peripheral arterial disease, often cause the formation of blood clots. In such cases, antiplatelet drugs play an important role in preventing these clots, thereby reducing the risk of heart attacks and strokes. Recent data reveals that around 620 million people are affected by heart and circulatory diseases worldwide, with about 60 million people developing the medical condition every year.  The rise in the global burden of cardiovascular diseases directly impacts the sales of antiplatelet drugs. Moreover, advancements in drug delivery technologies and the introduction of novel formulations in antiplatelet therapies are poised to impact the market positively.

Influx of Generic Drugs to Meet the Rising Antiplatelet Drugs Market Demand

The market is also influenced by the increased entry of generic equivalents of various popular antiplatelet drugs. For instance, in January 2023 , Indian multinational pharmaceutical company Lupin Limited announced that the United States Food and Drug Administration (FDA) has approved its Prasugrel Tablets USP, 5 mg and 10 mg, which are a generic version of Cosette Pharmaceuticals, Inc.’s Effient® Tablets. The rising introduction of such affordable generic drugs is likely to make treatment more accessible for a larger segment of the population, which is expected to boost market share. Additionally, the market is also impacted by the evolving medication guidelines and increased initiatives aimed at reducing the burden of cardiovascular diseases.

Global Antiplatelet Drugs Market By Distribution Channel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Antiplatelet Drugs Market Trends

Key Trend Impact
Increase in Aging Population Older adults are more susceptible to developing a cardiovascular condition. The rise in the aging population is resulting in a high prevalence rate of cardiovascular diseases and related conditions, which are primary indications for antiplatelet drugs. This shift is leading to increased usage of antiplatelet drugs, thereby fuelling market growth.
Rising Advancements in Drug Development Technological advancements and substantial investment in research and development are leading to the development of new antiplatelet agents with improved efficacy and fewer side effects. This enhances patient compliance, resulting in improved patient outcomes and increased market expansion.
Heightened Awareness of Cardiovascular Diseases The market share is also influenced by the rising global awareness and preventative screening for cardiovascular health, which are leading to earlier and more frequent use of antiplatelet drugs. This trend is contributing positively to market size and early treatment initiation.
Mergers and Acquisitions Activity Several market players are undergoing strategic mergers and acquisitions to enhance their research and development capabilities and expand their market reach. Such collaborations are expected to accelerate the development and distribution of new and existing antiplatelet drugs.

Global Antiplatelet Drugs Market Segmentation

Market Breakup by Drug
 

  • Aspirin
  • Clopidogrel
  • Ticagrelor
  • Prasugrel
  • Tirofiban
  • Others

Market Breakup by Drug Class

  • Platelet Aggregation Inhibitors
  • Glycoprotein Platelet Inhibitors
  • Others

Market Breakup by Applications

  • Myocardial Infarction
  • Ischemic Stroke
  • Angioplasty
  • Arterial Thrombosis
  • Others

Market Breakup by Route of Administration

  • Oral
  • Injectables
  • Other

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Antiplatelet Drugs Market Share

Aspirin Leads the Market Share in Drugs

The market segmentation by drug includes aspirin, clopidogrel, ticagrelor, prasugrel, tirofiban, and other medications, each targeting platelet aggregation through different mechanisms. Aspirin dominates this market segment due to its established efficacy and safety profile. The affordability of the drug has also contributed to its increased usage in the market.

Platelet Aggregation Inhibitors Dominate the Drug Classes Segment

In terms of drug class, the market includes platelet aggregation inhibitors, glycoprotein platelet inhibitors, and other classes of antiplatelet drugs, which indicate diverse pharmacological approaches to inhibiting platelet function. Platelet aggregation inhibitors such as aspirin, clopidogrel (Plavix), and ticagrelor (Brilinta) hold a significant market share due to increasing awareness of cardiovascular risks and the benefit of preventive medication.

Myocardial Infarction Emerges as the Major Application Area for Antiplatelet Drugs

Applications of antiplatelet drugs include myocardial infarction, ischemic stroke, angioplasty, arterial thrombosis, and other medical conditions. This market segment is dominated by myocardial infarction owing to the rising prevalence of the condition and the growing geriatric population. Moreover, the increased government initiatives to raise awareness regarding the management of myocardial infarction are poised to elevate the market value.

Global Antiplatelet Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Antiplatelet Drugs Market Analysis by Region

Based on the region, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with each region contributing to the overall dynamics of the market. North America holds the largest market share which can be attributed to the high prevalence and incidence of cardiovascular diseases. For instance, in the United States, heart disease is the leading cause of death across various demographic groups with approximately 805,000 people experiencing a heart attack every year. Further, substantial healthcare investments and increased accessibility of life-saving antiplatelet medications also boost the market growth in the regional market.

Leading Players in the Global Antiplatelet Drugs Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Bayer AG
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Daiichi Sankyo Company, Limited
  • Otsuka America Pharmaceutical, Inc.
  • AbbVie Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug
  • Drug Class
  • Applications
  • Route of Administration
  • Distribution Channel
  • Region
Breakup by Drug
  • Aspirin
  • Clopidogrel
  • Ticagrelor
  • Prasugrel
  • Tirofiban
  • Others
Breakup by Drug Class
  • Platelet Aggregation Inhibitors
  • Glycoprotein Platelet Inhibitors
  • Others
Breakup by Applications
  • Myocardial Infarction
  • Ischemic Stroke
  • Angioplasty
  • Arterial Thrombosis
  • Others
Breakup by Route of Administration
  • Oral
  • Injectables
  • Other
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Bayer AG
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Daiichi Sankyo Company, Limited
  • Otsuka America Pharmaceutical, Inc.
  • AbbVie Inc.

Key Queries Solved in the Global Antiplatelet Drugs Market Report

  • What was the global antiplatelet drugs market value in 2023?  
  • What is the global antiplatelet drugs market forecast outlook for 2024-2032?  
  • What are the major factors aiding the global market demand?  
  • What are the major global market trends? 
  • What is the market segmentation based on the drug?
  • What is the market segmentation based on the drug class?
  • What is the market breakup by route of administration?
  • What are the major distribution channels of antiplatelet drugs?
  • What are the application areas of antiplatelet drugs?
  • What are the major markets according to the EMR report? 
  • Who are the key players involved in the global antiplatelet drugs market?
  • How will the market landscape evolve in the upcoming years? 
  • What are the major drivers, opportunities, and restraints in the market? 
  • What will be the effect of each driver, challenge, and opportunity on the market? 
  • Which country is poised to lead the market share in the forecast period? 
  • Which country is expected to experience expedited growth during the forecast period? 
  • Which drug is expected to augment the antiplatelet drugs market size? 
  • Which drug class is poised to fuel the market share? 
  • Which route of administration is expected to dominate the respective market segment? Which applications are expected to significantly impact the growth of the market?
  • What are the key research initiatives expected to boost the market value during the forecast period?
  • Which distribution channel is anticipated to propel the market growth? 
  • Which segment has the highest impact on the market size? 
  • How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?

Antiplatelet Drugs Market Report Snapshots

Antiplatelet Drugs Market Size

Antiplatelet Drugs Market Growth

Antiplatelet Drugs Market Trends

Antiplatelet Drugs Market Share

Antiplatelet Drugs Market Regional Analysis

Antiplatelet Drugs Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124